Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter?. Curr Opin Hematol. 2015..
Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission. Am J Hematol. 2016.
Clonal Hematopoiesis as a Model for Premalignant Changes During Aging. Exp Hematol. 2019..
Guideline-based indicators for adult patients with myelodysplastic syndromes. Blood Adv. 2020;4(16):4029-4044.
Myelodysplastic Syndromes: Diagnosis and Treatment. Mayo Clin Proc. 2015;90(7):969-83..